Effectiveness of Chlorhexidine Bathing to Reduce Catheter-associated Bloodstream Infections in Medical Intensive Care Unit Patients
Overview
Authors
Affiliations
Objective: To determine whether patients bathed daily with chlorhexidine gluconate (CHG) have a lower incidence of primary bloodstream infections (BSIs) compared with patients bathed with soap and water.
Methods: The study design was a 52-week, 2-arm, crossover (ie, concurrent control group) clinical trial with intention-to-treat analysis. The study setting was the 22-bed medical intensive care unit (MICU), which comprises 2 geographically separate, similar 11-bed units, of the John H. Stroger Jr (Cook County) Hospital, a 464-bed public teaching hospital in Chicago, Illinois. The study population comprised 836 MICU patients. During the first of 2 study periods (28 weeks), 1 hospital unit was randomly selected to serve as the intervention unit in which patients were bathed daily with 2% CHG-impregnated washcloths (Sage 2% CHG cloths; Sage Products Inc, Cary, Illinois); patients in the concurrent control unit were bathed daily with soap and water. After a 2-week wash-out period at the end of the first period, cleansing methods were crossed over for 24 more weeks. Main outcome measures included incidences of primary BSIs and clinical (culture-negative) sepsis (primary outcomes) and incidences of other infections (secondary outcomes).
Results: Patients in the CHG intervention arm were significantly less likely to acquire a primary BSI (4.1 vs 10.4 infections per 1000 patient days; incidence difference, 6.3 [95% confidence interval, 1.2-11.0). The incidences of other infections, including clinical sepsis, were similar between the units. Protection against primary BSI by CHG cleansing was apparent after 5 or more days in the MICU.
Conclusion: Daily cleansing of MICU patients with CHG-impregnated cloths is a simple, effective strategy to decrease the rate of primary BSIs.
Prospective, crossover, comparative study of two methods of chlorhexidine bathing.
Hankins R, Handke L, Fey P, Cavalieri R, Cawcutt K, Van Schooneveld T Infect Control Hosp Epidemiol. 2025; :1-6.
PMID: 39880793 PMC: 11883645. DOI: 10.1017/ice.2024.243.
Chang H, Liu T, Huang P, Chen C, Yen C, Chen H Microorganisms. 2025; 13(1).
PMID: 39858834 PMC: 11767414. DOI: 10.3390/microorganisms13010065.
Fucini G, Abe R, Lemke E, Gastmeier P Antimicrob Resist Infect Control. 2024; 13(1):137.
PMID: 39551779 PMC: 11571737. DOI: 10.1186/s13756-024-01493-3.
Skin decontamination to prevent infections in the intensive care unit.
Bonten M, Tomazini B, Harbarth S Intensive Care Med. 2024; 50(12):2144-2145.
PMID: 39480518 DOI: 10.1007/s00134-024-07701-3.
Schaumburg T, Kohler N, Breitenstein Y, Kolbe-Busch S, Hasenclever D, Chaberny I Intensive Care Med. 2024; 50(12):2073-2082.
PMID: 39417875 PMC: 11588887. DOI: 10.1007/s00134-024-07667-2.